Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aadi Bioscience, Inc. (AADI) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aadi Bioscience, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1422142.
Total stock buying since 2017: $57,555,779.
Total stock sales since 2017: $4,800,039.
Total stock option exercises since 2017: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 10,643 | $25,010 | 28,000 | $0 |
| 2024 | 0 | $0 | 335,689 | $594,910 | 32,558 | $0 |
| 2023 | 0 | $0 | 378,000 | $2,273,115 | 0 | $0 |
| 2022 | 0 | $0 | 3,550 | $71,234 | 0 | $0 |
| 2021 | 1,789,400 | $23,399,982 | 0 | $0 | 0 | $0 |
| 2020 | 0 | $0 | 21,400 | $41,944 | 0 | $0 |
| 2019 | 153,818 | $325,168 | 1,750,446 | $1,773,156 | 0 | $0 |
| 2018 | 3,823,149 | $13,920,979 | 5,300 | $20,670 | 0 | $0 |
| 2017 | 3,981,930 | $19,909,650 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-03 | 0 | $0 | 10,643 | $25,010 | 28,000 | $0 |
| 2024-10 | 0 | $0 | 9,689 | $18,796 | 32,558 | $0 |
| 2024-09 | 0 | $0 | 40,000 | $68,320 | 0 | $0 |
| 2024-08 | 0 | $0 | 40,000 | $57,370 | 0 | $0 |
| 2024-07 | 0 | $0 | 40,000 | $57,221 | 0 | $0 |
| 2024-06 | 0 | $0 | 40,000 | $71,509 | 0 | $0 |
| 2024-05 | 0 | $0 | 40,000 | $77,200 | 0 | $0 |
| 2024-03 | 0 | $0 | 42,000 | $84,642 | 0 | $0 |
| 2024-02 | 0 | $0 | 42,000 | $73,290 | 0 | $0 |
| 2024-01 | 0 | $0 | 42,000 | $86,562 | 0 | $0 |
| 2023-12 | 0 | $0 | 42,000 | $211,714 | 0 | $0 |
| 2023-11 | 0 | $0 | 42,000 | $185,766 | 0 | $0 |
| 2023-10 | 0 | $0 | 42,000 | $179,011 | 0 | $0 |
| 2023-09 | 0 | $0 | 42,000 | $238,827 | 0 | $0 |
| 2023-08 | 0 | $0 | 42,000 | $218,773 | 0 | $0 |
| 2023-07 | 0 | $0 | 42,000 | $271,600 | 0 | $0 |
| 2023-06 | 0 | $0 | 42,000 | $338,762 | 0 | $0 |
| 2023-05 | 0 | $0 | 42,000 | $323,631 | 0 | $0 |
| 2023-04 | 0 | $0 | 42,000 | $305,031 | 0 | $0 |
| 2022-03 | 0 | $0 | 3,550 | $71,234 | 0 | $0 |
| 2021-08 | 1,789,400 | $23,399,982 | 0 | $0 | 0 | $0 |
| 2020-12 | 0 | $0 | 21,400 | $41,944 | 0 | $0 |
| 2019-07 | 10,000 | $8,559 | 0 | $0 | 0 | $0 |
| 2019-04 | 0 | $0 | 1,370,000 | $1,402,451 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-03 | Lennon David James (CHIEF EXECUTIVE OFFICER) | Sale | 5,690 | 2.35 | 13,371 |
| 2025-03-03 | Ball Bryan (See remarks) | Sale | 2,147 | 2.35 | 5,045 |
| 2025-03-03 | Giacobello Scott M. (CHIEF FINANCIAL OFFICER) | Sale | 2,806 | 2.35 | 6,594 |
| 2025-03-01 | Lennon David James (CHIEF EXECUTIVE OFFICER) | Option Ex | 16,250 | .00 | 0 |
| 2025-03-01 | Ball Bryan (See remarks) | Option Ex | 5,000 | .00 | 0 |
| 2025-03-01 | Giacobello Scott M. (CHIEF FINANCIAL OFFICER) | Option Ex | 6,750 | .00 | 0 |
| 2024-10-03 | Lennon David James (CHIEF EXECUTIVE OFFICER) | Sale | 9,689 | 1.94 | 18,796 |
| 2024-10-02 | Lennon David James (CHIEF EXECUTIVE OFFICER) | Option Ex | 32,558 | .00 | 0 |
| 2024-09-03 | Desai Neil (EXECUTIVE CHAIRMAN) | Sale | 40,000 | 1.71 | 68,320 |
| 2024-08-05 | Desai Neil (EXECUTIVE CHAIRMAN) | Sale | 5,652 | 1.34 | 7,596 |
| 2024-08-02 | Desai Neil (EXECUTIVE CHAIRMAN) | Sale | 18,933 | 1.41 | 26,714 |
| 2024-08-01 | Desai Neil (EXECUTIVE CHAIRMAN) | Sale | 15,415 | 1.50 | 23,060 |
| 2024-07-02 | Desai Neil (EXECUTIVE CHAIRMAN) | Sale | 8,652 | 1.34 | 11,610 |
| 2024-07-01 | Desai Neil (EXECUTIVE CHAIRMAN) | Sale | 31,348 | 1.46 | 45,611 |
| 2024-06-04 | Desai Neil (EXECUTIVE CHAIRMAN) | Sale | 20,225 | 1.77 | 35,737 |
| 2024-06-03 | Desai Neil (EXECUTIVE CHAIRMAN) | Sale | 19,775 | 1.81 | 35,772 |
| 2024-05-01 | Desai Neil (EXECUTIVE CHAIRMAN) | Sale | 40,000 | 1.93 | 77,200 |
| 2024-03-04 | Desai Neil (EXECUTIVE CHAIRMAN) | Sale | 14,964 | 2.10 | 31,409 |
| 2024-03-01 | Desai Neil (EXECUTIVE CHAIRMAN) | Sale | 27,036 | 1.97 | 53,233 |
| 2024-02-01 | Desai Neil (Executive Chairman) | Sale | 42,000 | 1.75 | 73,290 |
| 2024-01-02 | Desai Neil (Executive Chairman) | Sale | 42,000 | 2.06 | 86,562 |
| 2023-12-06 | Desai Neil (Executive Chairman) | Sale | 7,037 | 4.82 | 33,911 |
| 2023-12-05 | Desai Neil (Executive Chairman) | Sale | 15,740 | 5.01 | 78,936 |
| 2023-12-04 | Desai Neil (Executive Chairman) | Sale | 10,876 | 5.15 | 55,989 |
| 2023-12-01 | Desai Neil (Executive Chairman) | Sale | 8,347 | 5.14 | 42,878 |
| 2023-11-02 | Desai Neil (Executive Chairman) | Sale | 31,662 | 4.46 | 141,117 |
| 2023-11-01 | Desai Neil (Executive Chairman) | Sale | 10,338 | 4.32 | 44,649 |
| 2023-10-03 | Desai Neil (Executive Chairman) | Sale | 16,431 | 4.10 | 67,301 |
| 2023-10-02 | Desai Neil (Executive Chairman) | Sale | 25,569 | 4.37 | 111,710 |
| 2023-09-06 | Desai Neil (Executive Chairman) | Sale | 7,111 | 5.29 | 37,638 |
| 2023-09-05 | Desai Neil (Executive Chairman) | Sale | 21,000 | 5.63 | 118,314 |
| 2023-09-01 | Desai Neil (Executive Chairman) | Sale | 13,889 | 5.97 | 82,875 |
| 2023-08-02 | Desai Neil (Executive Chairman) | Sale | 19,290 | 5.20 | 100,250 |
| 2023-08-01 | Desai Neil (Executive Chairman) | Sale | 22,710 | 5.22 | 118,523 |
| 2023-07-06 | Desai Neil (Executive Chairman) | Sale | 15,829 | 6.27 | 99,279 |
| 2023-07-05 | Desai Neil (Executive Chairman) | Sale | 16,171 | 6.55 | 105,871 |
| 2023-07-03 | Desai Neil (Executive Chairman) | Sale | 10,000 | 6.64 | 66,450 |
| 2023-06-06 | Desai Neil (Executive Chairman) | Sale | 7,260 | 8.19 | 59,452 |
| 2023-06-05 | Desai Neil (Executive Chairman) | Sale | 17,315 | 8.11 | 140,424 |
| 2023-06-02 | Desai Neil (Executive Chairman) | Sale | 12,443 | 7.99 | 99,419 |
| 2023-06-01 | Desai Neil (Executive Chairman) | Sale | 4,982 | 7.92 | 39,467 |
| 2023-05-04 | Desai Neil (Executive Chairman) | Sale | 2,305 | 7.57 | 17,444 |
| 2023-05-03 | Desai Neil (Executive Chairman) | Sale | 7,695 | 7.68 | 59,074 |
| 2023-05-02 | Desai Neil (Executive Chairman) | Sale | 7,521 | 7.48 | 56,226 |
| 2023-05-01 | Desai Neil (Executive Chairman) | Sale | 24,479 | 7.80 | 190,887 |
| 2023-04-06 | Desai Neil (Executive Chairman) | Sale | 12,212 | 7.09 | 86,619 |
| 2023-04-05 | Desai Neil (Executive Chairman) | Sale | 7,336 | 7.24 | 53,075 |
| 2023-04-04 | Desai Neil (Executive Chairman) | Sale | 12,869 | 7.30 | 93,982 |
| 2023-04-03 | Desai Neil (Executive Chairman) | Sale | 9,583 | 7.45 | 71,355 |
| 2022-03-18 | Desai Neil (See Remarks) | Sale | 3,550 | 20.07 | 71,234 |
| 2021-08-26 | Dalal Anupam (Director) | Buy | 1,529,402 | 13.08 | 19,999,989 |
| 2021-08-26 | Castelein Caley (Director) | Buy | 259,998 | 13.08 | 3,399,993 |
| 2020-12-08 | Orbimed Capital Gp V Llc | Sale | 21,400 | 1.96 | 41,944 |
| 2019-07-10 | Gardner Joseph H. (President) | Buy | 5,000 | .81 | 4,074 |
| 2019-07-03 | Gardner Joseph H. (President) | Buy | 5,000 | .90 | 4,485 |
| 2019-04-26 | Novartis Ag (10% Owner) | Sale | 138,704 | 1.03 | 142,865 |
| 2019-04-25 | Novartis Ag (10% Owner) | Sale | 563,096 | 1.03 | 579,988 |
| 2019-04-24 | Novartis Ag (10% Owner) | Sale | 16,403 | 1.03 | 16,895 |
| 2019-04-23 | Novartis Ag (10% Owner) | Sale | 27,554 | 1.03 | 28,380 |
| 2019-04-22 | Novartis Ag (10% Owner) | Sale | 7,100 | .97 | 6,887 |
| 2019-04-15 | Novartis Ag (10% Owner) | Sale | 28,794 | .99 | 28,506 |
| 2019-04-12 | Novartis Ag (10% Owner) | Sale | 30,908 | 1.04 | 32,144 |
| 2019-04-11 | Novartis Ag (10% Owner) | Sale | 57,438 | 1.08 | 62,033 |
| 2019-04-10 | Novartis Ag (10% Owner) | Sale | 140,230 | 1.09 | 152,850 |
| 2019-04-09 | Novartis Ag (10% Owner) | Sale | 32,991 | 1.01 | 33,320 |
| 2019-04-08 | Novartis Ag (10% Owner) | Sale | 27,525 | 1.02 | 28,075 |
| 2019-04-05 | Novartis Ag (10% Owner) | Sale | 24,661 | 1.02 | 25,154 |
| 2019-04-04 | Novartis Ag (10% Owner) | Sale | 47,900 | 1.01 | 48,379 |
| 2019-04-03 | Novartis Ag (10% Owner) | Sale | 58,033 | .96 | 55,711 |
| 2019-04-02 | Novartis Ag (10% Owner) | Sale | 51,754 | .97 | 50,201 |
| 2019-04-01 | Novartis Ag (10% Owner) | Sale | 116,909 | .95 | 111,063 |
| 2019-03-29 | Novartis Ag (10% Owner) | Sale | 63,100 | .91 | 57,421 |
| 2019-03-28 | Novartis Ag (10% Owner) | Sale | 88,835 | .94 | 83,504 |
| 2019-03-27 | Novartis Ag (10% Owner) | Sale | 50,749 | .99 | 50,241 |
| 2019-03-26 | Novartis Ag (10% Owner) | Sale | 177,762 | 1.01 | 179,539 |
| 2019-01-10 | Satter Muneer A (Director) | Buy | 23,818 | 2.45 | 58,449 |
| 2019-01-09 | Satter Muneer A (Director) | Buy | 20,000 | 2.39 | 47,880 |
| 2019-01-08 | Satter Muneer A (Director) | Buy | 20,000 | 2.20 | 43,980 |
| 2019-01-07 | Satter Muneer A (Director) | Buy | 20,000 | 2.18 | 43,560 |
| 2019-01-04 | Satter Muneer A (Director) | Buy | 20,000 | 2.12 | 42,400 |
| 2019-01-03 | Satter Muneer A (Director) | Buy | 20,000 | 2.08 | 41,500 |
| 2019-01-02 | Satter Muneer A (Director) | Buy | 20,000 | 1.94 | 38,840 |
| 2018-12-31 | Satter Muneer A (Director) | Buy | 20,000 | 1.75 | 34,900 |
| 2018-12-28 | Satter Muneer A (Director) | Buy | 20,000 | 1.72 | 34,380 |
| 2018-12-27 | Satter Muneer A (Director) | Buy | 20,000 | 1.67 | 33,420 |
| 2018-12-26 | Satter Muneer A (Director) | Buy | 20,000 | 1.69 | 33,860 |
| 2018-12-21 | Satter Muneer A (Director) | Buy | 20,000 | 1.84 | 36,880 |
| 2018-12-20 | Satter Muneer A (Director) | Buy | 20,000 | 1.85 | 36,980 |
| 2018-12-19 | Satter Muneer A (Director) | Buy | 20,000 | 1.92 | 38,380 |
| 2018-12-18 | Satter Muneer A (Director) | Buy | 20,000 | 1.99 | 39,860 |
| 2018-12-14 | Satter Muneer A (Director) | Buy | 20,000 | 2.00 | 40,100 |
| 2018-12-13 | Satter Muneer A (Director) | Buy | 20,000 | 2.02 | 40,300 |
| 2018-12-12 | Satter Muneer A (Director) | Buy | 20,000 | 2.05 | 40,940 |
| 2018-12-11 | Satter Muneer A (Director) | Buy | 20,000 | 2.09 | 41,840 |
| 2018-12-10 | Satter Muneer A (Director) | Buy | 20,000 | 2.13 | 42,600 |
| 2018-12-07 | Satter Muneer A (Director) | Buy | 20,000 | 2.14 | 42,779 |
| 2018-12-06 | Satter Muneer A (Director) | Buy | 20,000 | 2.18 | 43,580 |
| 2018-12-04 | Satter Muneer A (Director) | Buy | 20,000 | 2.10 | 42,000 |
| 2018-12-03 | Satter Muneer A (Director) | Buy | 20,000 | 1.99 | 39,780 |
| 2018-11-30 | Satter Muneer A (Director) | Buy | 20,000 | 1.99 | 39,700 |
| 2018-11-29 | Satter Muneer A (Director) | Buy | 20,000 | 2.01 | 40,119 |
| 2018-11-28 | Satter Muneer A (Director) | Buy | 20,000 | 1.94 | 38,720 |
| 2018-11-12 | Hoffman Stephen J (Chief Executive Officer) | Buy | 30,000 | 2.01 | 60,299 |
| 2018-11-09 | Hoffman Stephen J (Chief Executive Officer) | Buy | 1,967 | 1.95 | 3,835 |
| 2018-08-20 | Novartis Ag (10% Owner) | Sale | 5,300 | 3.90 | 20,670 |
| 2018-06-28 | Orbimed Capital Gp V Llc | Buy | 777,500 | 3.85 | 2,993,375 |
| 2018-06-28 | Khuong Chau Quang | Buy | 777,500 | 3.85 | 2,993,375 |
| 2018-06-28 | Satter Muneer A (Director) | Buy | 1,818,182 | 3.85 | 7,000,000 |
| 2018-03-23 | Satter Muneer A (Director) | Buy | 1,000 | 5.00 | 5,000 |
| 2018-03-21 | Satter Muneer A (Director) | Buy | 4,000 | 4.85 | 19,392 |
| 2018-03-20 | Satter Muneer A (Director) | Buy | 5,400 | 4.97 | 26,859 |
| 2018-03-19 | Satter Muneer A (Director) | Buy | 7,600 | 4.96 | 37,726 |
| 2017-03-15 | Gardner Joseph H. (See Remarks) | Buy | 99,996 | 5.00 | 499,980 |
| 2017-03-15 | Peters Kevin G. (Chief Scientific Officer) | Buy | 3,642 | 5.00 | 18,210 |
| 2017-03-15 | Khuong Chau Quang (Director) | Buy | 762,995 | 5.00 | 3,814,975 |
| 2017-03-15 | Castelein Caley (Director) | Buy | 400,000 | 5.00 | 2,000,000 |
| 2017-03-15 | Satter Muneer A (Director) | Buy | 1,120,000 | 5.00 | 5,600,000 |
| 2017-03-15 | Weiss Paul M (Director) | Buy | 272,302 | 5.00 | 1,361,510 |
| 2017-03-15 | Novartis Ag (10% Owner) | Buy | 560,000 | 5.00 | 2,800,000 |
| 2017-03-15 | Isaly Samuel D (Director) | Buy | 762,995 | 5.00 | 3,814,975 |
Insider trading activities including stock purchases, stock sales, and option exercises of AADI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aadi Bioscience, Inc. (symbol AADI, CIK number 1422142) see the Securities and Exchange Commission (SEC) website.